OncoSec to sell about 1.6M shares at 1.25 per share in registered direct offer ONCS
ONCSDelisted Stock | USD 0.06 0 3.63% |
Slightly above 61% of OncoSec Medical's investor base is looking to short. The analysis of current outlook of investing in OncoSec Medical suggests that many traders are alarmed regarding OncoSec Medical's prospects. OncoSec Medical's investing sentiment can be driven by a variety of factors including economic data, OncoSec Medical's earnings reports, geopolitical events, and overall market trends.
OncoSec |
OncoSec Medical announced... ONCS
Read at thefly.com
OncoSec Medical Fundamental Analysis
We analyze OncoSec Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OncoSec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OncoSec Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
OncoSec Medical is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
OncoSec Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with OncoSec Medical stock to make a market-neutral strategy. Peer analysis of OncoSec Medical could also be used in its relative valuation, which is a method of valuing OncoSec Medical by comparing valuation metrics with similar companies.
Peers
OncoSec Medical Related Equities
ZVSA | ZyVersa Therapeutics | 4.23 | ||||
BDRX | Biodexa Pharmaceticals | 2.80 | ||||
ALLR | Allarity Therapeutics | 1.94 | ||||
VRAX | Virax Biolabs | 1.87 | ||||
UNCY | Unicycive Therapeutics | 1.64 | ||||
IMMX | Immix Biopharma | 0.97 | ||||
REVB | Revelation Biosciences | 2.44 | ||||
ATNF | 180 Life | 2.56 | ||||
QNRX | Quoin Pharmaceuticals | 3.39 | ||||
DRMA | Dermata Therapeutics | 4.32 | ||||
PHIO | Phio Pharmaceuticals | 10.47 | ||||
PALI | Palisade Bio | 10.84 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |